🎗️ OncologyTablet
Orserdu
Elacestrant
Oral selective estrogen receptor degrader (SERD) for ER-positive, HER2-negative breast cancer with ESR1 mutations.
Form
Tablet
Uses
1
Side effects
6
Category
Oncology
01
What is Orserdu used for?
- ER+/HER2- advanced breast cancer with ESR1 mutation
02
Elacestrant side effects
The following side effects have been reported for Elacestrant. Their order does not indicate how often an effect occurs.
Nausea
Musculoskeletal pain
Vomiting
Fatigue
Elevated cholesterol
Dyspepsia
03
Elacestrant warnings & precautions
- Embryo-fetal toxicity
- Monitor liver enzymes
- Not for use with strong CYP3A4 inhibitors
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Orserdu in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.